Pulmonary Embolism Risk Stratification: PESI, sPESI, and Outpatient Management

Risk Stratification: PESI and Simplified PESI

Pulmonary embolism spans a vast clinical spectrum — from the incidentally discovered subsegmental PE on a staging CT to the massive saddle embolus with hemodynamic collapse. The management of each is fundamentally different, and the clinical skill that separates excellent PE care from reflexive care is accurate risk stratification. Getting this right determines whether a patient is safely discharged home on oral anticoagulation, admitted for monitoring, or taken emergently for catheter-directed therapy or systemic thrombolysis. The tools for making this determination have matured considerably, and every clinician who diagnoses PE should be fluent in their use.

The Pulmonary Embolism Severity Index (PESI) uses 11 clinical variables to stratify 30-day mortality risk into five classes. PESI classes I-II (low risk, 30-day mortality 1.0-3.5%) are candidates for abbreviated hospital stays or outpatient management. The simplified PESI (sPESI) assigns one point each for age >80, cancer, heart failure/chronic lung disease, heart rate ≥110, systolic BP <100 mmHg, and SpO2 <90%. An sPESI of 0 identifies low-risk patients with 30-day mortality of 1.0% (95% CI 0.0-2.1%)[1], validated across multiple cohorts.

sPESI in the Emergency Department Workflow

The practical value of the sPESI is its speed and simplicity. You can calculate it at the bedside in under a minute with no laboratory data required beyond oxygen saturation. An sPESI of 0 — the patient is under 80, has no cancer or cardiopulmonary disease, heart rate is below 110, systolic BP is above 100, and oxygen saturation is 90% or above — immediately identifies a low-risk cohort that can be evaluated for outpatient management. This does not mean automatic discharge; it means the patient enters a lower-acuity pathway where additional criteria (Hestia, described below) determine whether outpatient treatment is appropriate. For the emergency physician balancing a full department, the sPESI provides a rapid, validated initial triage point.

Right Ventricular Dysfunction Assessment

The 2019 ESC guidelines classify PE into massive (high-risk: hemodynamic instability), submassive (intermediate-risk: RV dysfunction and/or elevated troponin), and low-risk. RV dysfunction (a form of acute right heart failure) is assessed by CT angiography (RV/LV ratio >0.9), echocardiography (RV dilation, hypokinesis, McConnell sign, TAPSE <16 mm), or biomarkers (elevated troponin or NT-proBNP >600 pg/mL)[2]. Intermediate-risk PE is further subdivided: intermediate-high (both RV dysfunction AND elevated troponin) carries 7-11% short-term mortality, while intermediate-low (one or neither) carries 3-5%.

Outpatient PE Management: Hestia Criteria

The idea that some PE patients can be safely managed entirely as outpatients was initially controversial, but the evidence now clearly supports it for appropriately selected low-risk patients. The clinical and economic implications are substantial: avoiding a 3-5 day hospital admission for a condition that can be safely treated at home with oral anticoagulation benefits both the patient and the healthcare system. The key is rigorous selection.

The Hestia criteria provide a practical 11-item checklist to identify PE patients safe for home treatment. Exclusion criteria include hemodynamic instability, need for thrombolysis, active bleeding, oxygen requirement, PE diagnosed on anticoagulation, severe pain requiring IV analgesics, medical or social reasons for admission, CrCl <30 mL/min, severe liver disease, pregnancy, and history of HIT. The Hestia validation study (OTPE trial) demonstrated 0.4% VTE recurrence and 0% mortality at 3 months among 297 outpatient-managed PE patients meeting Hestia criteria[3].

Making Outpatient PE Work in Practice

Even when a patient meets all Hestia criteria and has an sPESI of 0, outpatient management requires a reliable follow-up system. The patient needs a clear understanding of when to seek emergency care (worsening dyspnea, chest pain, hemoptysis, signs of bleeding), a confirmed prescription for their DOAC, and a follow-up appointment within 48-72 hours. Social factors matter as well — a patient who lives alone without reliable transportation to the emergency department if symptoms worsen may be better served by a brief observation period even if they technically qualify for outpatient management. The clinical criteria identify who can safely be treated at home; the practical criteria determine who should be.